Cytokinetics, Inc. (CYTK) Reports In-Line Q2 Loss of 13c/Share

July 31, 2012 4:49 PM

Cytokinetics, Inc. (NASDAQ: CYTK) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.

No results found